Alembic Pharmaceuticals share news, announcements and annual reports
NSE: APLLTDBSE: 533573Pharmaceuticals & BiotechnologySmall Cap
Alembic Pharmaceuticals Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2011
Last close ₹797.85up ₹3.00 (0.38%)BSE ₹797.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹794.85.
30 Oct: open ₹794.85, high ₹800.00, low ₹784.05
52-week range of traded prices to 30 Oct 2026
₹635.80Low, 23 Mar 2026₹998.00High, 4 Nov 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,683 Cr430th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.50%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 72,86569.4% delivered
Alembic Pharmaceuticals share news and announcements
971 announcements, routine notices left out, newest first. Page 20 of 20.
Aug 2012
29 Aug · Updates
Major part of the manufacturing operations at the Company's Panelav API -1, Manufacturing Unit have been restored. The work for restoration of balance portion is going on and is expected to be completed in another one week.27 Aug · Updates
There was fire at API 1 plant at Panelav in solvent recovery area at around 00.30 am on August 26, 2012. The fire was brought under control in about 3 hours of firefighting by fire brigade. The exact cause of fire is still not known and is being investigated. The Company are covered by insurance and have intimated insurance company about the accident. Detailed estimate of loss is being worked out. No human injury was reported, only security guard and 3 laborers received minor injuries / bruises while moving away from accident site13 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2012
26 Jul · Board meeting
Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.4 Jul · Meeting
Annual General Meeting of the Company shall be held on August 09, 2012. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from August 02, 2012 to August 09, 2012 (both days inclusive) for the purpose of declaration of dividend and Annual General Meeting of the Company for the F.Y. 2011-12.
Jun 2012
Apr 2012
25 Apr · Dividend
Board of Directors of the Company at its meeting held on April 25, 2012 has recommended dividend Rs.1.40 per Equity Share i.e. @ 70% on 18,85,15,914 Equity Shares of Rs.2/- each for the year ended on March 31, 2012.12 Apr · Board meeting
Inter alia, to transact following business : (1) To consider and approve Audited Financial statements of the Company for the Financial year ended March 31, 2012; (2) To recommend dividend for the Financial Year ended March 31, 2012.
Feb 2012
Jan 2012
17 Jan · Board meeting
Inter alia to consider and approve, the unaudited Financial Results of the Company for the quarter ended December 31, 2011.
Oct 2011
10 Oct · Board meeting
To consider and approve, inter alia, the unaudited Financial Results of the Company for the quarter ended September 30, 2011.